The CHEK2 protein is a cell cycle checkpoint regulator and a possible tumor suppressor that is known to phosphorylate BRCA1. Mutations in this gene have been correlated with the development of Li-Fraumeni syndrome. This mutation increases the likelihood of predisposition to sarcomas, breast cancer, and brain tumors. The gene discussed is CHEK2; the disease is breast carcinoma.